What Experimental Treatment Denial Means for Your Claim
Experimental treatment denial occurs when your insurance company refuses to cover a treatment or procedure that is not yet widely accepted or approved by medical authorities, such as the FDA or a professional medical organization. This can be a devastating blow for patients facing a life-threatening condition or chronic illness, as it may limit their access to necessary care.
How It Affects Your Coverage
Experimental treatment denial can have significant financial and emotional consequences for patients. You may be left with out-of-pocket costs for the treatment, which can be financially burdensome. Delays in treatment can also impact your health and quality of life. This type of denial applies to most insurance plans, including Medicare, Medicaid, and private insurance policies.
Your Legal Rights
As a patient, you have legal protections under federal and state laws. The Affordable Care Act (ACA) requires insurers to provide coverage for essential health benefits, including mental health and substance abuse services. The No Surprises Act prohibits balance billing for emergency services. The Mental Health Parity and Addiction Equity Act (MHPAEA) ensures equal coverage for mental health and substance abuse services. Ins